1. Home
  2. Live Updates
  3. Jonathan aschoff

Live Breaking News & Updates on Jonathan aschoff

Stay informed with the latest breaking news from Jonathan aschoff on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Jonathan aschoff and stay connected to the pulse of your community

Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q4 2023 Earnings Call Transcript

Helius Medical Technologies, Inc. beats earnings expectations. Reported EPS is $-1.47, expectations were $-4.05.

Canada , United-states , Brooks-rehabilitation-hospital , Florida , Quebec , Canadian , Michelle-bilski , Jonathan-aschoff , Steven-kautz , Jeff-cohen , Healthtech-connex , Dane-andreeff

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q4 2023 Earnings Call Transcript

Zevra Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.4 EPS, expectations were $-0.2.

France , French , Sumant-kulkarni , Neil-mcfarlane , Christal-mickle , Jonathan-aschoff , Oren-livnat , Laduane-clifton , Joshua-schafer , Nichol-ochsner , Corporate-communications-for-zevra-therapeutics , Drug-enforcement-administration

Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2023 Earnings Call Transcript

Operator: Good morning. And welcome to Cellectar Biosciences 2023 Yearend Earnings Call. Today's call is being recorded.

Florida , United-states , University-of-wisconsin , Wisconsin , Chad , American , America , Jim-caruso , Eric-gustafson , Alison-bautista , Shane-lea , Jarrod-longcor

Panbela Therapeutics, Inc. (NASDAQ:PBLA) Q4 2023 Earnings Call Transcript

Operator: Greetings. Welcome to Panbela Therapeutics Fourth Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.

China , Texas , United-states , Australia , American , Jennifer-simpson , Josh-korsen , Jonathan-aschoff , Joe-pantginis , Eflornithine-pediatric-neuroblastoma-program , American-society-of-hematology , Stock-market-exchange

Moleculin Biotech, Inc. (NASDAQ:MBRX) Q4 2023 Earnings Call Transcript

Operator: Greetings, welcome to the Moleculin Biotech 2023 Year-End Conference Call and Webcast. [Operator Instructions] Please note, that this conference is being recorded.

France , Virginia , United-states , French , John-paul-waymack , Barry-white , Jonathan-foster , Paul-waymack , Walter-klemp , Jenene-thomas , Jonathan-aschoff , Vernon-bernardino

RenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024

RenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Shaun-bagai , Jonathan-aschoff , Securities-exchange , Twitter , Senior-research-analyst-at-roth , Linkedin , Exchange-commission , Ritz-carlton , Renovorx-inc , Strategic-communications , Company-nasdaq , Chief-executive-officer

FWBI keeps "Buy" rating at Roth - Cantech Letter

Following news of an acquisition, Roth MKM analyst Jonathan Aschoff remains bullish on First Wave BioPharma

Chaitan-khosla , Jonathan-aschoff , James-sapirstein , Jack-syage , Stanford-university , First-wave-biopharma , First-wave-biopharma-stock-quote , First-wave , Professor-chaitan-khosla ,

Buy these stocks for a potentially choppy 2024, Roth MKM says

Roth MKM believes 2024 could prove to be a volatile year for stocks. Here are some of the firm's top picks.

Boston , Massachusetts , United-states , Cellectar-biosciences , Joseph-reagor , Rohit-kulkarni , Sam-adams , Philip-shen , Jonathan-aschoff , Federal-reserve , Drug-administration , Lithium-electric

Texas Biotech Advances Lead Candidate in Resistant AML

Texas Biotech Advances Lead Candidate in Resistant AML

Texas , United-states , Jonathan-aschoff , Path-holdings-inc , Nasdaq , Bio-path-holdings , Path-holdings , Investor-ideas , Biotech , Exas-biotech , Esistant-aml ,

Drugs Show Anti-Cancer Effects on Myeloma Cells

Drugs Show Anti-Cancer Effects on Myeloma Cells

Texas , United-states , Jonathan-aschoff , Nasdaq , University-of-texas-md-anderson-cancer-center , Panbela-therapeutics-inc , Cancer-center , Investor-ideas , Biotech , Rugs , Nti-cancer , Yeloma-cells